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The use of electroconvulsive therapy in the
treatment of psychiatric illness at
Umzimkulu Hospital in Transkei
A retrospective study
R. x. MUGISHA, E. B. L. OVUGA
Summary
Out of 1816 patients admitted to Umzimkulu Hospital between
1976 and 1982, 378 (20,8%) received electroconvulsive therapy
(ECn in combination with drugs. The use of ECT at this
hospital is described and comparisons are made between
ECT and non-ECT patients using length of stay in hospital as
the criterion variable. The percentage of patients receiving
ECT dropped from 32% in 1976 to 6% in 1982, when it was
discontinued. ECT patients tended to be slightly younger and
stayed in hospital a few days more. There was a tendency for
all groups of patients, male v. female, first admissions v.
previously admitted, to stay in hospital slightly longer if they
received ECT. It is suggested that the use of ECT in addition
to neuroleptics was probably a reflectio!l of the severity of
symptomatology.
S Atr Med J 1991; 79: 391-393.
Electroconvulsive therapy (ECT) was fIrst used in 1938 as a
treatment for schizophrenia. l The principle on which it was
introduced into clinical practice was the erroneous belief that
epilepsy and schizophrenia could not coexist in the same
patient and so it was conjectured that inducing a seizure by
electrical means would effectively treat schizophrenia.
The technique consists of passing an electric current through
the head either by placing an electrode on either side of the
head (bilateral ECT) or placing both electrodes on the same
side (unilateral EeT). The electric current induces an epileptic-
like seizure, which is believed to be the therapeutic agent. The
modified form of ECT involves the administration of an
anaesthetic and muscle relaxant with the additional use of
oxygen delivered to the patient through a mask. These are
regarded as necessary precautions to minimising the risk of
fractures and dislocations (mainly of the jaw), which KendelF.
has reported affected 'up to 30% of patients in some series'.
However, in under-developed countries, the unmodifIed form
of ECT is still practised, possibly due to lack of professional
skills and other resources needed for the modffied form.
The effIcacy of ECT, its clinical indications and contra-
indications, mode of administration, public attitudes, etc. have'
been discussed at length by Kendell. 2 It is generally believed
that ECT is effective for treating depression and is often found
to be the only choice for patients who have failed to respond to
drugs or who have refused to eat or those who are at great risk
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of committing suicide. On the other hand, the effIcacy of ECT
in the treatment of schizophrenia has been a subject of heated
debate, and 'Salzman3 concluded that relevant studies on the
subject have been unable to give conclusive evidence con-
cerning the superiority of ECT. He observed that most of the
studies did not meet acceptable research criteria and he felt
that the subject needed further study. Abraham and Kulhara4
performed a small double-blind trial in which a group of 11
patients were allocated randomly to an ECT-trifluoperazine
combination and another group of 11 patients to a simulated
ECT-trifluoperazine regimen. The recovery of the patients
was monitored over a period of 26 weeks and it was found that
ECT accelerated the process of recovery within the flrst 12
weeks. However, during the subsequent weeks, the superiority
of ECT could not be ascertained; this same phenomenon had
been reported earlier by Tay10r and F1eminger5 and Brandon
er a1.6
The fmdings of a retrospective study of the use of ECT in
the treatment of psychiatric patients at Umzimkulu Hospital
are reported. We describe the fequency of its use from 1976,
when the hospital was established, up to 1982 when ECT was
discontinued. In addition, we report on some comparisons
made on two groups of patients who were treated with similar
drugs with or without ECT, using length of stay in hospital as
the criterion variable.
Methods and results
A detailed review of 1816 case notes was carried out and it
was found that 378 patients (20,8%) had received BCT in
combination with drugs. During the fIrst 2 years of the
hospital's existence, nearly 30% of patients received ECT but
in subsequent years the percentage dropped substantially. The
. observed percentages of ECT recipients were as follows: 1976
- 32%; 1977 - 31%; 1978 - 16%; 1979 - 13%; 1980 - 17%;
1981 - 12%; 1982 - 6%.
Of the 378 patients who were treated with ECT, 311' or
82,5% were diagnosed as having schizophrenia (including cata-
tonic schizophrenia 6%; chronic schizophrenia 4%). The
remaining patients had a variety of diagnoses including: epi-
lepsy 8 patients; alcoholism or cannabis abuse 5; senile dementia
4; depression 4; undetermined 4; not recorded 7.
Among the 1438 patients who did not receive ECT, 64%
were diagnosed as schizophrenics, 9% as epileptics; and 7% as
suffering from alcoholism or cannabis abuse. In this group
there were a total of 10 patients diagnosed as depressives and
multiple diagnoses were common.
Thus, the two groups of ECT and non-ECT patients were
quite heterogeneous, not only in terms of diagnoses, but also
in respect of medication. From the 1816 patients a subgroup
of 414 was chosen consisting entirely of schizophrenics who
were treated either with fluphenazine decanoate (Modecate;
Squibb) and chlorpromazine (Largactil; Maybaker) or with
fluphenazine decanoate, chlorpromazine and haloperidol
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(Serenace; Searle), in combination with ECT or without ECT.
This subgroup was studied to [rod out whether ECf was
effective in reducing the length of stay in hospital among
patients who had received almost identical medication.
of days spent in hospital for ECT recipients and non-E<;f
patients are given in Table 1.
Discussion
In the treatment of schizophrenia ECf is believed to be
benefIcial in ameliorating catatonic symptoms and excitement.4



















TABLE I. MEAN LENGTH OF STAY IN HOSPITAL (DAYS)













On the basis of the leaving experience of patients in different
groups (Table I), the 'survivor functions' were estimated for
weddy intervals using the life-table procedure of the S~tistical
Analyser Systems computer package.7 Classic life:-table esti-
mates based on survivor functions were made along the lines
suggested by Barclay,8 and 'duration expectan~', similar to
life expectancy in classic life-tables, was computed. The results
are shown in Table II and it is apparent that patients.who
were treated on medication alone stayed in hospital for a
marginally shorter period of time (uniformly at time X;
measured in weeks) than patients who received ECf in addition
to neuroleptics.
Characteristics of selected patients
Among the subgroup of 414 patients there were 121 ECT
recipients and 293 non-recipients. There were 299 men of
whom 86 had received ECf, and 115 women of whom 35 had
been treated with ECf. All patients in this subgroup were
schizophrenics who were treated with fluphenaziI;1e decanoate.
(1 ml injection on admisson and then 1 ml/mo.) and chlor-
promazine (300 mgld) with or without ECf. ECT was
administered within a period not exceeding 10 days, the
majority receiving the treatment every day for 7 days. No
further ECT was administered. Unfortunately, the records did
not indicate whether unilateral or bilateral ECT was given but
it is known that all patients received the unmodified form in
which no anaesthetic was administered. For many patients
chlorpromazine was either reduced after the period of ECT to
150 mgld or it was replaced by trifluoperazine 15 mg 3 times a
day. The decision to administer ECf was always made at the
fIrst examination by a medical officer, which often took place
on the fIrst or second day after admission to hospital.
The mean age ofECT recipients was 30,7 ± 9,9 years and it
was found to be significantly lower than the mean age of non-
ECT patients (34,3 ± 12 years; P < 0,005). Male patients were
generally younger (mean 32,8 years) than female patients
(mean 35,6 years; P < 0,015). However, in the analysis of
variance the sex':'ECf interaction was not statistically signifIcant
(P = 0,33), indicating that men or women who received ECT
were generally as old as men or women who did not receive
ECT (ECf male patients - mean 30,2 years, female patients
- mean 31,9 years; non-ECT male patients - mean 33,3
years; female patients - mean 37,2 years). There were 332
fIrst admissions' and 82 patients who had been admitted to a
psychiatric hospital at least once before in the subgroup.
The 86 male patients who received ECT stayed in hospital
for an average of 65,1 days compared with 58,9 days for male
patients on medication only. The analysis of variance gave a
non-significant sex-ECT interaction for the length of stay in
hospital (P = 0,65) and neither the sex effect (P = 0,47) nor
the ECT effect (P = 0,27) were signilicant. The mean number
TABLE 11. DURATION EXPECTANCY AT WEEK X FOR SCHIZOPHRENIC PATIENTS RECEIVING ECT AND NOT
RECEIVING ECT*
Previously
All 414 patients Men Women Rrst admissions admitted
Week X E NE E NE E NE E NE E NE
No. of
patients 121 293 86 213 35 80 98 234 23 59
0 9,3 '8,6 9,4 8,4 9,3 9,1 9,4 8,9 9,0 i,8
1 8,3 7,6 8,4 7,5 8,3 8,1 8,4 7,9 8,0 6,8
2 7,3 6,7 7,4 &,5 7,3 7,1 7,4 6,9 7,0 5,8
3 6,4 6,0 6,5 5,9 6,3 6,1 6,5 6,2 6,0 5,1
4 6,2 5,4 6,6 5,5 5,3 5,2 6,3 5,7 5,6 3,9
5 5,7 5,0 6,4 5,3 4,6 4,4 5,7 5,3 6,3 3,5
6 5,8 5,1 6,6 5,7 4,2 4,1 6,2 5,1 5,8 3,4
7 6,1 5,3 7,1 6,0 4,3 4,1 5,9 5,8 5,3 3,3
8 5,8 5,2 6,4 5,9 4,4 4,0 6,1 5,8 5,3 3,3
9 5,8 5,3 6,1 6,0 5,0 4,1 5,9 5,9 7,8 3,3
10 5,9 6,0 6,0 6,7 5,5 4,3 6,9 6,5 6,6 3,5
E = patients who rlIC8Mld ECT treatment; NE = non-ECT patients.
treating acute than chronic schizophrenia. In this study we
found that the difference in duration expectancy for the period
spent in hospital at week X was more pronounced between
ECT recipients and those patients who were treated on drug
therapy in the previously admitted category. This was also
reflected in the mean duration, which was 63,0 days for ECT
patients and 54,2 days for those who received medication
alone, among patients who had been previously admitted.
However, since the analysis of variance did not show a signifi-
cant ECT effect, and because the number of patients in the
ECT group who had previously been admitted was small,
these observations cannot be viewed as conclusive. On the
other hand, ECT did not give shoner duration expectancy for
any of the categories in Table II.
The duration expectancy can be given the same interpretation
as life expectancy in life-tables. This number incorporates the
leaving experience of a group of persons at each preselected
point in time, X, and it can be defmed as the average length of
stay expected for those individuals who have survived up to
time X. Although the common arithmetic mean of the length
of stay is easily understood and is subject to well-known
statistical laws, such as the central limit theorem, in a study
involving members of a population subjected to different risks
at different points in time, the life-table measure is more
appropriate.
Studies· of the effect of ECT-drug combinations on the
length of stay in hospital have produced conflicting results.
Among the studies that reponed shoner duration are those of
Kincross-Wright9 and Rhode and Sargant lO while the study of
Salzman,3 quoting extensively from published repons, found
longer duration for ECT patients than for those treated on
drugs alone.
In this study we have reponed that at Umzimkulu Hospital
a very large proportion of psychiatric patients were given ECT
(almost 30% in the period 1976 - 1977 and 21% for 1976 -
1982). The conclusion is that ECT was used routinely in
clinical practice at the hospital, particularly in the earlier years
of the hospital's existence. In several states in the USA,
however, the use of ECT has been cunailed by legislation and
KendelF has reponed that between 3% and 5% of psychiatric
patients receive ECT in Europe and North America. This
study also showed that ECT patients within the subgroup of
schizophrenic patients tended to be younger than those treated
on neuroleptics alone. This could be partly explained by the
fact that the unmodified form of ECT was administered and
therefore care had to be exercised in choosing patients who
were likely to suffer minimal side-effects from ECT treatment.
Apan from this, there do not seem to have been clear-cut
selection criteria for ECT. On the other hand, the decision to
administer ECT in addition to neuroleptics could have been a
reflection of severity of symptoms or indeed of an affective
component to the primary condition. Could this then explain
why ECT patients tended to stay in hospital for a slighdy
longer period or was the increased length of stay a reflection of
inadequate treatment for schizophrenia among black patients?
Concerning the issue of whether the discontinuation of ECT
at Umzimkulu Hospital was correct - making a case for ECT,
Kende1l2 stated that until drugs of comparable efficacy and
safety are developed: 'It is essential that ECT should remain
freely available on the same terms as any other treatment.
Psychiatrists have too few effective therapies at their disposal
to be able to afford the luxury of dispensing with what is still
the most dramatically effective of them all.' Similarly, Rahmanll
expressed a positive opinion of ECT in the treatment of
schizophrenia in Pakistan, which is a developing country.
Abraham and Kulhara,4 working in India, also thought that
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the use of ECT could be cost-effective since it seemed to
speed up the process of recovery in schizophrenic patients. It
would seem that more studies are needed regarding the role of
ECT 'in the treatment of psychiatric illness in developing
countries. An important issue will be to address the operational
problems regarding the administration of ECT, including the
maintenance of ECT equipment. Kende1l2 reponed that in one
health region in England, 50 faults were found in 18 ECT
machines in regular use, and it is likely that, given the
technological advancement in England, these faults were recti-
fied as soon as they were discovered. However, at many rural
hospitals in Mrica and other Third-World countries there may
be no personnel easily available to check for faults in ECT
machines, let alone rectify them.
The debate on whether to re-introduce ECT at Umzimkulu
Hospital is continuing. This hospital is a very imponant
institution with a catchment area of nearly 3 million people
and therefore it is not surprising that some depressed patients,
who could possibly benefit from ECT, present at the hospital.
The extreme policy of abandoning the treatment in 1982 could
have resulted from the other extreme policy of large-scale use
without careful evaluation of its beneficial effects. But, in view
of the documentary evidence from other pans of the world
concerning the efficacy of ECT, a controlled policy for its
administration, including strict selection criteria, seems to be
necessary. Like many other hospitals in developing countries,
Umzimkulu Hospital has had the problem of high staff turn-
over with doctors coming from different pans of the world
having different training orientations in different cultural
settings. While this is not a bad thing per se, we would argue
that this phenomenon does not help to sustain much continuity
in respect of establishing specific traditions within a hospital.
For continuity to be maintained in the context of ECT admini-
stration, a documentation system would be needed to enable a
clinician to assess the efficacy of the treatment over a long
period in relation to specified categories of patients coming to
the hospital.
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